Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 76351 - 76375 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Tamibarotene	Investigational	BRCA2	675	downregulated	tamibarotene results in decreased expression of BRCA2 mRNA	13q13.1	A24376
Tamibarotene	Investigational	BTG2	7832	upregulated	tamibarotene results in increased expression of BTG2 mRNA	1q32.1	A24376
Tamibarotene	Investigational	CADM1	23705	upregulated	tamibarotene results in increased expression of CADM1 mRNA	11q23.3	A24376
Tamibarotene	Investigational	CAMK1	8536	upregulated	tamibarotene results in increased expression of CAMK1 mRNA	3p25.3	A24376
Tamibarotene	Investigational	CAMTA2	23125	upregulated	tamibarotene results in increased expression of CAMTA2 mRNA	17p13.2	A24376
Tamibarotene	Investigational	CAPG	822	upregulated	tamibarotene results in increased expression of CAPG mRNA	2p11.2	A24376
Tamibarotene	Investigational	CAPRIN1	4076	downregulated	tamibarotene results in decreased expression of CAPRIN1 mRNA	11p13	A24376
Tamibarotene	Investigational	CASP9	842	upregulated	tamibarotene results in increased expression of CASP9 mRNA	1p36.21	A24376
Tamibarotene	Investigational	CCDC93	54520	downregulated	tamibarotene results in decreased expression of CCDC93 mRNA	2q14.1	A24376
Tamibarotene	Investigational	CCL4	6351	upregulated	tamibarotene results in increased expression of CCL4 mRNA	17q12	A24376
Tamibarotene	Investigational	CCL5	6352	upregulated	tamibarotene results in increased expression of CCL5 mRNA	17q12	A24376
Tamibarotene	Investigational	CCND1	595	upregulated	tamibarotene results in increased expression of CCND1 mRNA	11q13.3	A24376
Tamibarotene	Investigational	CCNF	899	downregulated	tamibarotene results in decreased expression of CCNF mRNA	16p13.3	A24376
Tamibarotene	Investigational	CCR1	1230	upregulated	tamibarotene results in increased expression of CCR1 mRNA	3p21.31	A24376
Tamibarotene	Investigational	CD300A	11314	upregulated	tamibarotene results in increased expression of CD300A mRNA	17q25.1	A24376
Tamibarotene	Investigational	CD300C	10871	upregulated	tamibarotene results in increased expression of CD300C mRNA	17q25.1	A24376
Tamibarotene	Investigational	CD38	952	upregulated	tamibarotene results in increased expression of CD38 mRNA	4p15.32	A24376 A20513
Tamibarotene	Investigational	CD44	960	downregulated	tamibarotene results in decreased expression of CD44 mRNA	11p13	A20516
Tamibarotene	Investigational	CD53	963	upregulated	tamibarotene results in increased expression of CD53 mRNA	1p13.3	A24376
Tamibarotene	Investigational	CD74	972	upregulated	tamibarotene results in increased expression of CD74 mRNA	5q33.1	A20516
Tamibarotene	Investigational	CD79A	973	upregulated	tamibarotene results in increased expression of CD79A mRNA	19q13.2	A20516
Tamibarotene	Investigational	CDC25A	993	downregulated	tamibarotene results in decreased expression of CDC25A mRNA	3p21.31	A24376
Tamibarotene	Investigational	CDC6	990	downregulated	tamibarotene results in decreased expression of CDC6 mRNA	17q21.2	A24376
Tamibarotene	Investigational	CDKN1A	1026	upregulated	tamibarotene results in increased expression of CDKN1A mRNA	6p21.2	A20516
Tamibarotene	Investigational	CEBPB	1051	upregulated	tamibarotene results in increased expression of CEBPB mRNA	20q13.13	A24376

Displaying entries 76351 - 76375 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability